Body of Evidence Supporting the Use of Toraymyxin(TM) for Treatment of Septic Shock Continues to Grow
TORONTO, ONTARIO -- (Marketwired) -- 10/19/15 -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT)(OTCQX: EDTXF), a Phase III company developing the first treatment for patients with septic shock that comprises a …